FN2 Earnings Intelligence
UnitedHealth Group Incorporated financials
UnitedHealth Group Incorporated (UNH) financial statements and key operating metrics from FN2 Research.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - |
| - Cash | $21,375 | $23,365 | $25,427 | $25,312 | $24,365 |
| + Debt | - | $57,623 | $62,537 | $76,904 | $78,389 |
| Enterprise Value | - | - | - | - | - |
| Revenue | $287,597 | $324,162 | $371,622 | $400,278 | $447,567 |
| % Growth | 11.8% | 12.7% | 14.6% | 7.7% | 11.8% |
| Gross Profit | $256,563 | $290,459 | $332,852 | $353,584 | $396,912 |
| % Margin | 89.2% | 89.6% | 89.6% | 88.3% | 88.7% |
| EBITDA | $27,073 | $31,835 | $36,330 | $36,386 | $23,325 |
| % Margin | 9.4% | 9.8% | 9.8% | 9.1% | 5.2% |
| Net Income | $17,285 | $20,120 | $22,381 | $14,405 | $12,056 |
| % Margin | 6.0% | 6.2% | 6.0% | 3.6% | 2.7% |
| Diluted EPS | $18.08 | $21.18 | $23.86 | $15.51 | $13.23 |
| % Growth | 12.8% | 17.1% | 12.7% | -35.0% | -14.7% |
| Operating Cash Flow | $22,343 | $26,206 | $29,068 | $24,204 | $19,697 |
| CapEx | $2,454 | $2,802 | $3,386 | $3,499 | $3,622 |
| Free Cash Flow | $19,889 | $23,404 | $25,682 | $20,705 | $16,075 |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Revenue | $287,597 | $324,162 | $371,622 | $400,278 | $447,567 |
| Gross Profit | $256,563 | $290,459 | $332,852 | $353,584 | $396,912 |
| EBITDA | $27,073 | $31,835 | $36,330 | $36,386 | $23,325 |
| Net Income | $17,285 | $20,120 | $22,381 | $14,405 | $12,056 |
| Diluted EPS | $18.08 | $21.18 | $23.86 | $15.51 | $13.23 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $21,375 | $23,365 | $25,427 | $25,312 | $24,365 |
| Short-term Debt | - | $3,110 | $4,274 | $4,545 | $6,069 |
| Long-term Debt | $42,383 | $54,513 | $58,263 | $72,359 | $72,320 |
| Total Debt | - | $57,623 | $62,537 | $76,904 | $78,389 |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $22,343 | $26,206 | $29,068 | $24,204 | $19,697 |
| Capital Expenditure | $2,454 | $2,802 | $3,386 | $3,499 | $3,622 |
| Free Cash Flow | $19,889 | $23,404 | $25,682 | $20,705 | $16,075 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Revenue Growth | 11.8% | 12.7% | 14.6% | 7.7% | 11.8% |
| Gross Margin | 89.2% | 89.6% | 89.6% | 88.3% | 88.7% |
| EBITDA Margin | 9.4% | 9.8% | 9.8% | 9.1% | 5.2% |
| Net Margin | 6.0% | 6.2% | 6.0% | 3.6% | 2.7% |
| FCF Margin | 6.9% | 7.2% | 6.9% | 5.2% | 3.6% |
| Diluted EPS Growth | 12.8% | 17.1% | 12.7% | -35.0% | -14.7% |